Previous studies showed that blocking of the PD-L1/PD-L2 and PD-1 interaction can reestablish the T cell function and can mediate anti-tumour activity by reducing cancer cell proliferation and migration [58]. The gene discussed is PDCD1LG2; the disease is neoplasm.